Comprehensive Geriatric Assessment in Knee Osteoarthritis
Launched by UNIVERSITY OF PALERMO · Dec 13, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
Osteoarthritis (OA) is the most common form of arthritis, and is characterized by joint pain and stiffness leading to functional decline and relevant loss in quality of life. The incidence of OA is rising due to the aging population and an increase in some risk factors, such as obesity. Knee OA is the most common OA localization, and symptomatic knee OA is highly prevalent among people aged over 50 years, affecting more than 250 million people worldwide.
Knee OA is a leading cause of pain in older people, and pain of the hip and knee results in physical disability and an increased risk of ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Both genders
- • Age \> 70 years; able to sign the informed consent
- • Diagnosis of knee OA according to standardized criteria in Grade 1 (doubtful narrowing of joint space and possible osteophytic lipping), Grade 2 (definite osteophytes and possible narrowing of joint space) Kellgren and Lawrence system or Grade 3 (moderate multiple osteophytes, definite narrowing of joint space and some sclerosis and possible deformity of bone ends).
- Exclusion Criteria:
- • Expected life expectancy less than 6 months
- • Previous orthopedic surgery, in the three months before the enrolment or a planned orthopedic intervention in the next 6 months.
Trial Officials
Nicola Veronese, MD
Principal Investigator
University of Palermo
About University Of Palermo
The University of Palermo, a distinguished institution located in Italy, is dedicated to advancing medical research and education through innovative clinical trials. Renowned for its commitment to scientific excellence, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct research that addresses critical healthcare challenges. By fostering collaborations with leading researchers and healthcare professionals, the University of Palermo aims to translate scientific findings into effective therapies, ultimately contributing to improved patient outcomes and public health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials